Howard Berman - 27 Feb 2023 Form 4 Insider Report for Coya Therapeutics, Inc. (COYA)

Role
Chief Executive Officer, Director
Signature
/s/ David Snyder, Attorney-in-Fact
Issuer symbol
COYA
Transactions as of
27 Feb 2023
Net transactions value
$0
Form type
4
Filing time
01 Mar 2023, 15:05:30 UTC
Previous filing
17 Jan 2023
Next filing
02 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COYA Stock Option (right to buy) Award $0 +165,000 $0.000000 165,000 27 Feb 2023 Common Stock 165,000 $3.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to continuous service, the shares subject to the option vest in equal monthly installments over a period of 36 months commencing on March 27, 2023.